MicroSectors Gold Miners 3X Leveraged ETN

Direxion Daily Gold Miners Bull 3X ETF

VanEck Vectors Gold Miners ETF

Direxion Daily 20+ Yr Trsy Bull 3X ETF

VS TR 2x Long VIX Futures ETF

VanEck Vectors Junior Gold Miners ETF

Direxion Daily Technology Bull 3X ETF

ProShares Ultra VIX Short-Term Futures

ProShares Trust ProShares Short Bitcoin Strategy ETF

Direxion Daily Small Cap Bear 3X ETF

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

Direxion Daily Gold Miners Bear 3X ETF

Direxion Daily 20+ Yr Trsy Bear 3X ETF

Direxion Technology Bear 3X Shares

Bank Of Montreal

ARK Innovation ETF

ProShares Bitcoin Strategy ETF

Direxion Daily Small Cap Bull 3X ETF

ProShares UltraShort Bloomberg Natrl Gas

Oracle Corporation Common Stock

Vistra Corp. Common Stock

JELD-WEN Holding Inc. Common Stock

EQT Corporation Common Stock

Unity Software Inc. Common Stock

Eldorado Gold Corporation Ordinary Shares

Agnico Eagle Mines Limited Common Stock

Ciena Corporation Common Stock

UnitedHealth Group Incorporated Common Stock (DE)

Gold Fields Limited American Depositary Shares

GameStop Corporation Common Stock

Carvana Co. Class A Common Stock

XPeng Inc. American depositary shares each representing two Class A ordinary shares

Boeing Company (The) Common Stock

Bunge Limited Bunge Limited

Cloudflare Inc. Class A Common Stock

AMC Entertainment Holdings Inc. Class A Common Stock

JinkoSolar Holding Company Limited American Depositary Shares (each representing 4 Common Shares)

Oklo Inc.

Archer Aviation Inc. Class A Common Stock

Click here to get full coverage on Biotech Hits A 'Home Run' And Slams Its Two Key Rivals - Investor's Business Daily

Biotech Hits A 'Home Run' And Slams Its Two Key Rivals  Investor's Business Daily

Biotech Hits A 'Home Run' And Slams Its Two Key Rivals - Investor's Business Daily

Click here to get full coverage on Insmed CEO Will Lewis on stock surge after positive trial results - CNBC

Insmed CEO Will Lewis on stock surge after positive trial results  CNBC

Insmed CEO Will Lewis on stock surge after positive trial results - CNBC

Click here to get full coverage on Insmed's 'unprecedented' phase 2 PAH win sends stock soaring as the race to phase 3 kicks off - Fierce Pharma

Insmed's 'unprecedented' phase 2 PAH win sends stock soaring as the race to phase 3 kicks off  Fierce Pharma

Insmed's 'unprecedented' phase 2 PAH win sends stock soaring as the race to phase 3 kicks off - Fierce Pharma

Click here to get full coverage on Insmed Stock Jumps 28% on Experimental Hypertension Drug Trial Results - Barron's

Insmed Stock Jumps 28% on Experimental Hypertension Drug Trial Results  Barron's

Insmed Stock Jumps 28% on Experimental Hypertension Drug Trial Results - Barron's

Click here to get full coverage on Liquidia stock, United Therapeutics stock fall on Insmed data - Seeking Alpha

Liquidia stock, United Therapeutics stock fall on Insmed data  Seeking Alpha

Liquidia stock, United Therapeutics stock fall on Insmed data - Seeking Alpha

Click here to get full coverage on Clinical Trial Breakthrough: Insmed's Once-Daily PAH Drug Achieves 60% Reduction in Cardiac Stress Markers - Stock Titan

Clinical Trial Breakthrough: Insmed's Once-Daily PAH Drug Achieves 60% Reduction in Cardiac Stress Markers  Stock Titan

Clinical Trial Breakthrough: Insmed's Once-Daily PAH Drug Achieves 60% Reduction in Cardiac Stress Markers - Stock Titan

Click here to get full coverage on 13 Biotech Stocks with Huge Upside Potential - Insider Monkey

13 Biotech Stocks with Huge Upside Potential  Insider Monkey

13 Biotech Stocks with Huge Upside Potential - Insider Monkey

Click here to get full coverage on Insmed Announces Proposed $650 Million Public Offering of Common Stock - Yahoo Finance

Insmed Announces Proposed $650 Million Public Offering of Common Stock  Yahoo Finance

Insmed Announces Proposed $650 Million Public Offering of Common Stock - Yahoo Finance

Click here to get full coverage on $100 Invested In Insmed 10 Years Ago Would Be Worth This Much Today - Benzinga

$100 Invested In Insmed 10 Years Ago Would Be Worth This Much Today  Benzinga

$100 Invested In Insmed 10 Years Ago Would Be Worth This Much Today - Benzinga

Click here to get full coverage on Stocks making the biggest moves midday: Topgolf Callaway, Insmed, J.M. Smucker, SolarEdge and more - CNBC

Stocks making the biggest moves midday: Topgolf Callaway, Insmed, J.M. Smucker, SolarEdge and more  CNBC

Stocks making the biggest moves midday: Topgolf Callaway, Insmed, J.M. Smucker, SolarEdge and more - CNBC

Click here to get full coverage on Insmed Raises Massive $750M in Stock Offering to Advance Breakthrough Drug Pipeline - Stock Titan

Insmed Raises Massive $750M in Stock Offering to Advance Breakthrough Drug Pipeline  Stock Titan

Insmed Raises Massive $750M in Stock Offering to Advance Breakthrough Drug Pipeline - Stock Titan

Click here to get full coverage on Insmed is an attractive, but expensive takeout meal - statnews.com

Insmed is an attractive, but expensive takeout meal  statnews.com

Insmed is an attractive, but expensive takeout meal - statnews.com

Click here to get full coverage on Insmed (INSM) Secures $750 Million Through Stock Offering - GuruFocus

Insmed (INSM) Secures $750 Million Through Stock Offering  GuruFocus

Insmed (INSM) Secures $750 Million Through Stock Offering - GuruFocus

Click here to get full coverage on Insmed prices capital raise of $750 via stock offering - MSN

Insmed prices capital raise of $750 via stock offering  MSN

Insmed prices capital raise of $750 via stock offering - MSN

Click here to get full coverage on Insmed Stock Soars on Pulmonary Arterial Hypertension Drug Trial Results - Investopedia

Insmed Stock Soars on Pulmonary Arterial Hypertension Drug Trial Results  Investopedia

Insmed Stock Soars on Pulmonary Arterial Hypertension Drug Trial Results - Investopedia

Click here to get full coverage on Insmed Incorporated's (NASDAQ:INSM) Shares Climb 40% But Its Business Is Yet to Catch Up - simplywall.st

Insmed Incorporated's (NASDAQ:INSM) Shares Climb 40% But Its Business Is Yet to Catch Up  simplywall.st

Insmed Incorporated's (NASDAQ:INSM) Shares Climb 40% But Its Business Is Yet to Catch Up - simplywall.st

Click here to get full coverage on Insmed Prices Public Offering Of About 7.81 Mln Shares At $96.00/shr - Nasdaq

Insmed Prices Public Offering Of About 7.81 Mln Shares At $96.00/shr  Nasdaq

Insmed Prices Public Offering Of About 7.81 Mln Shares At $96.00/shr - Nasdaq

Click here to get full coverage on INSM Increases Common Stock Offering to $750M | INSM Stock News - GuruFocus

INSM Increases Common Stock Offering to $750M | INSM Stock News  GuruFocus

INSM Increases Common Stock Offering to $750M | INSM Stock News - GuruFocus

Click here to get full coverage on Stocks To Watch: Insmed Sees RS Rating Jump To 93 - Investor's Business Daily

Stocks To Watch: Insmed Sees RS Rating Jump To 93  Investor's Business Daily

Stocks To Watch: Insmed Sees RS Rating Jump To 93 - Investor's Business Daily

Click here to get full coverage on Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension - Yahoo Finance

Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension  Yahoo Finance

Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension - Yahoo Finance

Click here to get full coverage on INSM: Mizuho Raises Price Target for Insmed to $110 | INSM Stock News - GuruFocus

INSM: Mizuho Raises Price Target for Insmed to $110 | INSM Stock News  GuruFocus

INSM: Mizuho Raises Price Target for Insmed to $110 | INSM Stock News - GuruFocus

Click here to get full coverage on Insmed CEO Takes Stage at Goldman Sachs Healthcare Conference: Key Updates Expected - Stock Titan

Insmed CEO Takes Stage at Goldman Sachs Healthcare Conference: Key Updates Expected  Stock Titan

Insmed CEO Takes Stage at Goldman Sachs Healthcare Conference: Key Updates Expected - Stock Titan

Click here to get full coverage on Insmed Stock Jumps 29% on Encouraging PAH Study Results - Yahoo Finance

Insmed Stock Jumps 29% on Encouraging PAH Study Results  Yahoo Finance

Insmed Stock Jumps 29% on Encouraging PAH Study Results - Yahoo Finance

Click here to get full coverage on Insmed (INSM) Plans $650M Public Offering of Common Stock | INSM - GuruFocus

Insmed (INSM) Plans $650M Public Offering of Common Stock | INSM  GuruFocus

Insmed (INSM) Plans $650M Public Offering of Common Stock | INSM - GuruFocus

Click here to get full coverage on New Analyst Forecast: $INSM Given 'Buy' Rating - Nasdaq

New Analyst Forecast: $INSM Given 'Buy' Rating  Nasdaq

New Analyst Forecast: $INSM Given 'Buy' Rating - Nasdaq

Click here to get full coverage on Insmed surges on lung drug data; Recursion cuts staff - BioPharma Dive

Insmed surges on lung drug data; Recursion cuts staff  BioPharma Dive

Insmed surges on lung drug data; Recursion cuts staff - BioPharma Dive

Click here to get full coverage on $INSM stock is up 27% today. Here's what we see in our data. - Nasdaq

$INSM stock is up 27% today. Here's what we see in our data.  Nasdaq

$INSM stock is up 27% today. Here's what we see in our data. - Nasdaq

Click here to get full coverage on Insmed: Company Presses On With Further POC PAH Treatment Data (NASDAQ:INSM) - Seeking Alpha

Insmed: Company Presses On With Further POC PAH Treatment Data (NASDAQ:INSM)  Seeking Alpha

Insmed: Company Presses On With Further POC PAH Treatment Data (NASDAQ:INSM) - Seeking Alpha

Click here to get full coverage on Analyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM) - Insider Monkey

Analyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM)  Insider Monkey

Analyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM) - Insider Monkey

Click here to get full coverage on Insmed raises $750 million in public offering of common stock - Investing.com

Insmed raises $750 million in public offering of common stock  Investing.com

Insmed raises $750 million in public offering of common stock - Investing.com

Click here to get full coverage on Insmed aims to raise $750M in one of the largest stock offerings this year - Endpoints News

Insmed aims to raise $750M in one of the largest stock offerings this year  Endpoints News

Insmed aims to raise $750M in one of the largest stock offerings this year - Endpoints News

Click here to get full coverage on Insmed Prices $750 Million Common Stock Offering - marketscreener.com

Insmed Prices $750 Million Common Stock Offering  marketscreener.com

Insmed Prices $750 Million Common Stock Offering - marketscreener.com

Click here to get full coverage on Insmed Announces Pricing of $750 Million Public Offering of Comm - GuruFocus

Insmed Announces Pricing of $750 Million Public Offering of Comm  GuruFocus

Insmed Announces Pricing of $750 Million Public Offering of Comm - GuruFocus

Click here to get full coverage on S&P 500 Futures Steady in Premarket Trading; Insmed, Casey's General Stores Lead - Barron's

S&P 500 Futures Steady in Premarket Trading; Insmed, Casey's General Stores Lead  Barron's

S&P 500 Futures Steady in Premarket Trading; Insmed, Casey's General Stores Lead - Barron's

Click here to get full coverage on Insmed (INSM) Price Target Raised by Leerink Partners | INSM Stock News - GuruFocus

Insmed (INSM) Price Target Raised by Leerink Partners | INSM Stock News  GuruFocus

Insmed (INSM) Price Target Raised by Leerink Partners | INSM Stock News - GuruFocus

Click here to get full coverage on Insmed (INSM) Plans $650M Stock Offering, Shares Fall - GuruFocus

Insmed (INSM) Plans $650M Stock Offering, Shares Fall  GuruFocus

Insmed (INSM) Plans $650M Stock Offering, Shares Fall - GuruFocus

Click here to get full coverage on U.S. Indexes Moved Upward Tuesday; Insmed Led Increases - Barron's

U.S. Indexes Moved Upward Tuesday; Insmed Led Increases  Barron's

U.S. Indexes Moved Upward Tuesday; Insmed Led Increases - Barron's

Click here to get full coverage on Insmed Announces Proposed $650 Million Public Offering of Common Stock | INSM Stock News - GuruFocus

Insmed Announces Proposed $650 Million Public Offering of Common Stock | INSM Stock News  GuruFocus

Insmed Announces Proposed $650 Million Public Offering of Common Stock | INSM Stock News - GuruFocus

Click here to get full coverage on Insmed (INSM) Price Target Raised to $120 by HC Wainwright & Co. | INSM Stock News - GuruFocus

Insmed (INSM) Price Target Raised to $120 by HC Wainwright & Co. | INSM Stock News  GuruFocus

Insmed (INSM) Price Target Raised to $120 by HC Wainwright & Co. | INSM Stock News - GuruFocus

Click here to get full coverage on Insmed (INSM) Maintains Outperform Rating as Price Target Rises - GuruFocus

Insmed (INSM) Maintains Outperform Rating as Price Target Rises  GuruFocus

Insmed (INSM) Maintains Outperform Rating as Price Target Rises - GuruFocus

Click here to get full coverage on Insmed stock soars to 52-week high, touches $92.35 - Investing.com

Insmed stock soars to 52-week high, touches $92.35  Investing.com

Insmed stock soars to 52-week high, touches $92.35 - Investing.com

Click here to get full coverage on Insmed (INSM) Sees Price Target Raised by B of A Securities | INSM Stock News - GuruFocus

Insmed (INSM) Sees Price Target Raised by B of A Securities | INSM Stock News  GuruFocus

Insmed (INSM) Sees Price Target Raised by B of A Securities | INSM Stock News - GuruFocus

Click here to get full coverage on Insmed (INSM) Stock Target Raised by Morgan Stanley Due to Promi - GuruFocus

Insmed (INSM) Stock Target Raised by Morgan Stanley Due to Promi  GuruFocus

Insmed (INSM) Stock Target Raised by Morgan Stanley Due to Promi - GuruFocus

Click here to get full coverage on Insmed (INSM) Target Price Raised by Goldman Sachs | INSM Stock News - GuruFocus

Insmed (INSM) Target Price Raised by Goldman Sachs | INSM Stock News  GuruFocus

Insmed (INSM) Target Price Raised by Goldman Sachs | INSM Stock News - GuruFocus

Click here to get full coverage on Noteworthy Tuesday Option Activity: DXC, DK, INSM - Nasdaq

Noteworthy Tuesday Option Activity: DXC, DK, INSM  Nasdaq

Noteworthy Tuesday Option Activity: DXC, DK, INSM - Nasdaq

Click here to get full coverage on Biggest stock movers Tuesday: LMNR, NVO, INSM, and more (CBRL:NASDAQ) - Seeking Alpha

Biggest stock movers Tuesday: LMNR, NVO, INSM, and more (CBRL:NASDAQ)  Seeking Alpha

Biggest stock movers Tuesday: LMNR, NVO, INSM, and more (CBRL:NASDAQ) - Seeking Alpha

Click here to get full coverage on Insmed (INSM) Receives Price Target Increase from Wells Fargo | INSM Stock News - GuruFocus

Insmed (INSM) Receives Price Target Increase from Wells Fargo | INSM Stock News  GuruFocus

Insmed (INSM) Receives Price Target Increase from Wells Fargo | INSM Stock News - GuruFocus

Click here to get full coverage on Insmed (INSM) Receives Boosted Price Target from Wells Fargo | INSM Stock News - GuruFocus

Insmed (INSM) Receives Boosted Price Target from Wells Fargo | INSM Stock News  GuruFocus

Insmed (INSM) Receives Boosted Price Target from Wells Fargo | INSM Stock News - GuruFocus

Click here to get full coverage on Insmed (INSM) Target Price Boosted Following Positive Trial Resu - GuruFocus

Insmed (INSM) Target Price Boosted Following Positive Trial Resu  GuruFocus

Insmed (INSM) Target Price Boosted Following Positive Trial Resu - GuruFocus

Click here to get full coverage on Insmed Stock Ends Volatile Session Lower, Pauses After Monumental 32% Weekly Surge - Daily Chhattisgarh News

Insmed Stock Ends Volatile Session Lower, Pauses After Monumental 32% Weekly Surge  Daily Chhattisgarh News

Insmed Stock Ends Volatile Session Lower, Pauses After Monumental 32% Weekly Surge - Daily Chhattisgarh News

Click here to get full coverage on Insmed (INSM) Receives Boosted Price Target from Wells Fargo | I - GuruFocus

Insmed (INSM) Receives Boosted Price Target from Wells Fargo | I  GuruFocus

Insmed (INSM) Receives Boosted Price Target from Wells Fargo | I - GuruFocus

Click here to get full coverage on Insmed (INSM) Sees Price Target Boost Amid Strong PAH Data | INSM Stock News - GuruFocus

Insmed (INSM) Sees Price Target Boost Amid Strong PAH Data | INSM Stock News  GuruFocus

Insmed (INSM) Sees Price Target Boost Amid Strong PAH Data | INSM Stock News - GuruFocus

Click here to get full coverage on Insmed (INSM) Target Price Boosted Following Promising Phase 2 Results | INSM Stock News - GuruFocus

Insmed (INSM) Target Price Boosted Following Promising Phase 2 Results | INSM Stock News  GuruFocus

Insmed (INSM) Target Price Boosted Following Promising Phase 2 Results | INSM Stock News - GuruFocus

Click here to get full coverage on Insmed (INSM) Sees Boost with Positive Phase 2b Trial Results | INSM Stock News - GuruFocus

Insmed (INSM) Sees Boost with Positive Phase 2b Trial Results | INSM Stock News  GuruFocus

Insmed Inc (INSM)

Price Chart

Key Statistics

Technicals

About INSM

Latest News

Biotech Hits A 'Home Run' And Slams Its Two Key Rivals - Investor's Business Daily

Insmed CEO Will Lewis on stock surge after positive trial results - CNBC

Insmed's 'unprecedented' phase 2 PAH win sends stock soaring as the race to phase 3 kicks off - Fierce Pharma

Advanced Charts

Top Gainers

Top Losers